gabapentin has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 1 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)
Excerpt | Relevance | Reference |
---|---|---|
"Healthcare costs for CIDP patients are substantial, with a large burden in pharmacy usage." | 1.40 | Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. ( Bromberg, MB; Guptill, JT; Krueger, A; Sanders, DB; Sharma, BK; Thompson, AR; Zhu, L, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guptill, JT | 1 |
Bromberg, MB | 1 |
Zhu, L | 1 |
Sharma, BK | 1 |
Thompson, AR | 1 |
Krueger, A | 1 |
Sanders, DB | 1 |
1 other study available for gabapentin and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Article | Year |
---|---|
Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
Topics: Adolescent; Adult; Aged; Algorithms; Amines; Analgesics; Anti-Inflammatory Agents; Comorbidity; Cost | 2014 |